Burke Fred 4

What Happened
Fred Burke, President, Chief Executive Officer and a director of Guardian Pharmacy Services, Inc. (GRDN), was granted an option award for 75,000 shares on February 11, 2026. The award is reported as a derivative acquisition (code A) at $0.00 at grant — no cash was paid at issuance. The option vests and becomes exercisable in full on February 11, 2029.

Key Details

• Transaction date: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely under Form 4 rules).
• Transaction type: Option award (derivative grant), 75,000 shares, reported acquisition price $0.00.
• Vesting/exercise: Footnote states the option vests and becomes exercisable in full on 2029-02-11.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• No indication of immediate exercise or sale; this is a grant of future rights, not a market purchase/sale.

Context
Option grants to executives are common as long-term compensation and alignment with shareholder value; they do not represent an immediate purchase or sale of stock. Because the option vests three years from grant, the award ties potential upside to future performance and holding-period requirements. The filing does not show an exercise price or whether any plan conditions beyond the vesting date apply.